http://bridgebio.com
BridgeBio Pharma, Inc. Company Intro
Targeting Genetic Diseases at Their Source
Industry
Healthcare
BridgeBio Pharma, Inc. Headquaters
421 Kipling Street
Palo Alto,94301
United States
BridgeBio Pharma, Inc. Share price
17 May 2023 12:50 GMT
$14.47
-0.37 (-2.49 %)
BridgeBio Pharma, Inc. Market cap
$2.309 B
WMC RANKING
2024
BridgeBio Pharma, Inc. # 200
BiotechnologyLatest BridgeBio Pharma, Inc. News
12 Feb 2024
Boehringer Ingelheim and CBmed Join Forces
Boehringer Ingelheim and CBmed GmbH Centre for Biomarker Research in Medicine (CBmed) announced a long-term strategic partnership.
12 Feb 2024
Alys Pharmaceuticals Launches with $100M Financing from Medicxi
Alys Pharmaceuticals, Inc, an immuno-dermatology focused company, launches today with an R&D pipeline enabled by multiple platform technologies and a $100...
12 Feb 2024
Chanelle Pharma Acquired by Exponent
Chanelle Pharma has been sold by its founder Michael H Burke to Exponent, a leading private equity firm.
WMC Market Score
WMC Market to Revenue Score
BridgeBio Pharma, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| BridgeBio Pharma, Inc. | USD | $8,711 | $548,210 | $-519,953 | $23,090B | 200 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ 0.00 | 3 |
| ALK-Abello A/S | USD | $3,556,000 | $1,893,000 | $66,000 | $189,400B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total BridgeBio Pharma, Inc. Social Followers vs Top 4 Industry Competitors
BridgeBio Pharma, Inc. Post vs Top 4 Industry Competitors
BridgeBio Pharma, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
BridgeBio Pharma, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
BridgeBio Pharma, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| BridgeBio Pharma, Inc. | 0.09 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 70 | 0 | 0 | 39.85 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 100 | 0 | 0 | 51.56 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 80 | 0 | 0 | 100 |
| ALK-Abello A/S | 38.66 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
